- 20.4k views
Rational Use of Antibiotics in Critically ill Patients
The rational use of antibiotics in critically ill patients is paramount to combating infections while minimizing the risk of antimicrobial resistance. Clinicians must base antibiotic selection on a thorough understanding of the patient's clinical condition, local epidemiology, and potential pathogens. Tailoring therapy through de-escalation strategies and incorporating diagnostic tools like blood cultures ensures targeted treatment. Additionally, adherence to dosing regimens and regular reassessment of the patient's response are essential to optimize efficacy and prevent unnecessary antibiotic exposure. This judicious approach aligns with antimicrobial stewardship principles, promoting patient safety and preserving the effectiveness of antibiotics for future use in critical care settings.
About the Speaker
Dr. Supradip Ghosh
Director and Head, Department of Critical Care Medicine, Fortis-Escorts Hospital, Faridabad
Dr. Supradip Ghosh, a highly accomplished intensivist, brings a wealth of experience and expertise to the field of critical care medicine. Currently serving as a Consultant Intensivist and Head of the Department of Critical Care Medicine at Fortis-Escorts Hospital in Faridabad, India, he has been contributing significantly to the healthcare landscape since November 2009. Dr. Ghosh's academic journey includes obtaining his MBBS from Manipur University, DNB in Internal Medicine from the National Board of Examinations, and MRCP (UK) from the Royal College of Physicians in Edinburgh. His commitment to advancing critical care is evident through his role as Director of the Multidisciplinary Adult Intensive Care Unit, where he oversees the management of a diverse range of critical cases. With a keen interest in resuscitation, antimicrobial stewardship, and non-invasive respiratory support, Dr. Ghosh is also recognized for his teaching and training contributions. He is an accredited teacher and examiner for various critical care programs, actively participating in teaching activities and workshops. Dr. Ghosh has authored numerous book chapters and articles, demonstrating his commitment to knowledge dissemination in the field. His ongoing research projects and leadership roles in committees underscore his dedication to improving the quality of critical care services. As a Fellow of the Indian College of Critical Care Medicine and a member of professional societies, Dr. Supradip Ghosh continues to play a pivotal role in shaping critical care practices in India. Dr. Supradip Ghosh, a highly accomplished intensivist, brings a wealth of experience and expertise to the field of critical care medicine. Currently serving as a Consultant Intensivist and Head of the Department of Critical Care Medicine at Fortis-Escorts Hospital in Faridabad, India, he has been contributing significantly to the healthcare landscape since November 2009. Dr. Ghosh's academic journey includes obtaining his MBBS from Manipur University, DNB in Internal Medicine from the National Board of Examinations, and MRCP (UK) from the Royal College of Physicians in Edinburgh. His commitment to advancing critical care is evident through his role as Director of the Multidisciplinary Adult Intensive Care Unit, where he oversees the management of a diverse range of critical cases. With a keen interest in resuscitation, antimicrobial stewardship, and non-invasive respiratory support, Dr. Ghosh is also recognized for his teaching and training contributions. He is an accredited teacher and examiner for various critical care programs, actively participating in teaching activities and workshops. Dr. Ghosh has authored numerous book chapters and articles, demonstrating his commitment to knowledge dissemination in the field. His ongoing research projects and leadership roles in committees underscore his dedication to improving the quality of critical care services. As a Fellow of the Indian College of Critical Care Medicine and a member of professional societies, Dr. Supradip Ghosh continues to play a pivotal role in shaping critical care practices in India.
Upcoming Case Discussions
H. pylori Treatment with PYELRA®: Best Practices
PYLERA® is a medication used for the treatment of Helicobacter pylori (H. pylori) infection, a common cause of stomach ulcers and gastritis. It contains a combination of three active ingredients: bismuth subcitrate potassium, metronidazole, and tetracycline. This combination works synergistically to eradicate H. pylori bacteria and reduce associated symptoms. Treatment with PYLERA® typically involves taking multiple capsules four times a day for a specified duration, as prescribed by a healthcare provider. It is important to follow the treatment regimen as directed and to discuss potential side effects
Alcoholic Hepatitis: Management Strategies
Management of alcoholic hepatitis involves a comprehensive approach aimed at halting disease progression, managing symptoms, and promoting liver recovery. The cornerstone of treatment involves complete alcohol cessation to prevent further liver damage and promote healing. Patients often have malnutrition, so nutritional therapy with a focus on adequate protein intake and vitamin supplementation is crucial. Corticosteroids like prednisolone may be prescribed in severe cases to reduce liver inflammation and improve survival rates. In severe cases unresponsive to medical therapy, liver transplantation may be considered, although strict criteria must be met. Diuretics may be used cautiously to manage ascites while monitoring for renal function. Prophylactic measures such as beta-blockers may be used to reduce the risk of variceal bleeding.
Pneumonia in Children
Pneumonia in children is often caused by viral or bacterial infections, leading to inflammation of the lungs. Symptoms may include cough, fever, rapid breathing, and chest pain. Diagnosis typically involves physical examination, chest X-ray, and sometimes blood tests or other imaging studies. Treatment may include antibiotics for bacterial pneumonia, supportive care such as rest, fluids, and fever management, and in severe cases, hospitalization for oxygen therapy and close monitoring. Vaccination against common pathogens like Streptococcus pneumoniae and Haemophilus influenzae type b can help prevent pneumonia in children.
New Developments in Interventional Cardiology
Recent advancements in interventional cardiology have witnessed the evolution of cutting-edge techniques and technologies aimed at improving patient outcomes. From innovative stent designs to refined imaging modalities and minimally invasive procedures, interventional cardiologists now have a broader arsenal to address complex coronary artery disease. Drug-eluting stents with novel coatings aim to reduce restenosis rates, while bioresorbable scaffolds offer the promise of temporary vessel support without long-term metal implantation. Moreover, advances in imaging, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), enable more precise lesion assessment and optimized stent placement. Additionally, the advent of transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis, offering a less invasive option for high-risk patients. These developments underscore the continuous pursuit of innovation in interventional cardiology, striving for enhanced patient care, and improved long-term outcomes.
Patient Centric Care in Critical Care
Patient-centric care in critical care is a holistic approach that places the patient at the center of medical decision-making and treatment processes. It prioritizes the individual's preferences, values, and needs, considering not only their medical condition but also their emotional and psychological well-being. This approach involves clear communication, shared decision-making, and active involvement of patients and their families in care planning. Healthcare providers strive to deliver personalized care that respects the patient's dignity, autonomy, and cultural beliefs, aiming to optimize outcomes and enhance overall quality of life.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Supradip Ghosh's Talks on Assimilate
- 24th-February-2024, TIME : 7:00PM - 8:00PM
- 0
The rational use of antibiotics in critically ill patients is paramount to combating infections while minimizing the risk of antimicrobial resistance. Clinicians must base antibiotic selection on a thorough understanding of the patient's clinical condition, local epidemiology, and potential pathogens. Tailoring therapy through de-escalation strategies and incorporating diagnostic tools like blood cultures ensures targeted treatment. Additionally, adherence to dosing regimens and regular reassessment of the patient's response are essential to optimize efficacy and prevent unnecessary antibiotic exposure. This judicious approach aligns with antimicrobial stewardship principles, promoting patient safety and preserving the effectiveness of antibiotics for future use in critical care settings.